nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C19—prostate cancer	0.163	0.611	CbGaD
Loratadine—CYP3A4—prostate cancer	0.104	0.389	CbGaD
Loratadine—CYP2C8—Nilutamide—prostate cancer	0.0293	0.0589	CbGbCtD
Loratadine—CYP2C19—Nilutamide—prostate cancer	0.0246	0.0494	CbGbCtD
Loratadine—CYP2C19—Bicalutamide—prostate cancer	0.0246	0.0494	CbGbCtD
Loratadine—CYP2C8—Abiraterone—prostate cancer	0.0243	0.0488	CbGbCtD
Loratadine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0226	0.0455	CbGbCtD
Loratadine—CYP2C9—Nilutamide—prostate cancer	0.0204	0.0411	CbGbCtD
Loratadine—CYP2C9—Bicalutamide—prostate cancer	0.0204	0.0411	CbGbCtD
Loratadine—CYP2C19—Flutamide—prostate cancer	0.0203	0.041	CbGbCtD
Loratadine—CYP2D6—Bicalutamide—prostate cancer	0.0187	0.0376	CbGbCtD
Loratadine—ABCB1—Estramustine—prostate cancer	0.0184	0.0371	CbGbCtD
Loratadine—CYP2C8—Cabazitaxel—prostate cancer	0.0179	0.0361	CbGbCtD
Loratadine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0156	0.0315	CbGbCtD
Loratadine—CYP2D6—Abiraterone—prostate cancer	0.0155	0.0311	CbGbCtD
Loratadine—CYP2C9—Estrone—prostate cancer	0.0122	0.0246	CbGbCtD
Loratadine—ABCB1—Cabazitaxel—prostate cancer	0.0121	0.0245	CbGbCtD
Loratadine—CYP3A4—Bicalutamide—prostate cancer	0.0119	0.0239	CbGbCtD
Loratadine—ABCB1—Estrone—prostate cancer	0.0119	0.0239	CbGbCtD
Loratadine—CYP3A4—Estramustine—prostate cancer	0.011	0.0222	CbGbCtD
Loratadine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0106	0.0213	CbGbCtD
Loratadine—CYP2C8—Estradiol—prostate cancer	0.0101	0.0203	CbGbCtD
Loratadine—CYP3A4—Abiraterone—prostate cancer	0.00984	0.0198	CbGbCtD
Loratadine—CYP3A4—Flutamide—prostate cancer	0.00984	0.0198	CbGbCtD
Loratadine—CYP2C9—Capecitabine—prostate cancer	0.00927	0.0187	CbGbCtD
Loratadine—CYP2C19—Estradiol—prostate cancer	0.00845	0.017	CbGbCtD
Loratadine—ABCB1—Conjugated Estrogens—prostate cancer	0.00776	0.0156	CbGbCtD
Loratadine—CYP3A4—Cabazitaxel—prostate cancer	0.00728	0.0147	CbGbCtD
Loratadine—CYP2C19—Prednisone—prostate cancer	0.00727	0.0146	CbGbCtD
Loratadine—CYP3A4—Estrone—prostate cancer	0.00711	0.0143	CbGbCtD
Loratadine—ABCB1—Mitoxantrone—prostate cancer	0.00706	0.0142	CbGbCtD
Loratadine—CYP2C9—Estradiol—prostate cancer	0.00702	0.0141	CbGbCtD
Loratadine—ABCB1—Estradiol—prostate cancer	0.00682	0.0137	CbGbCtD
Loratadine—CYP2C8—Etoposide—prostate cancer	0.00658	0.0132	CbGbCtD
Loratadine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00634	0.0128	CbGbCtD
Loratadine—ABCB1—Prednisone—prostate cancer	0.00586	0.0118	CbGbCtD
Loratadine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00465	0.00937	CbGbCtD
Loratadine—ABCB1—Etoposide—prostate cancer	0.00445	0.00896	CbGbCtD
Loratadine—CYP3A4—Mitoxantrone—prostate cancer	0.00423	0.00852	CbGbCtD
Loratadine—CYP3A4—Estradiol—prostate cancer	0.00408	0.00822	CbGbCtD
Loratadine—ABCB1—Docetaxel—prostate cancer	0.00407	0.0082	CbGbCtD
Loratadine—CYP3A4—Prednisone—prostate cancer	0.00351	0.00707	CbGbCtD
Loratadine—ABCB1—Doxorubicin—prostate cancer	0.00304	0.00611	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—prostate cancer	0.00286	0.00576	CbGbCtD
Loratadine—CYP3A4—Etoposide—prostate cancer	0.00267	0.00537	CbGbCtD
Loratadine—CYP3A4—Docetaxel—prostate cancer	0.00244	0.00491	CbGbCtD
Loratadine—CYP2C19—urine—prostate cancer	0.002	0.146	CbGeAlD
Loratadine—CYP3A4—Doxorubicin—prostate cancer	0.00182	0.00366	CbGbCtD
Loratadine—CYP2C9—urine—prostate cancer	0.00155	0.113	CbGeAlD
Loratadine—Ketotifen—PDE4D—prostate cancer	0.00121	0.584	CrCbGaD
Loratadine—CYP3A4—urine—prostate cancer	0.00118	0.0861	CbGeAlD
Loratadine—CYP2D6—urine—prostate cancer	0.00116	0.0848	CbGeAlD
Loratadine—KCNH2—prostate gland—prostate cancer	0.000685	0.0499	CbGeAlD
Loratadine—KCNH2—seminal vesicle—prostate cancer	0.00058	0.0422	CbGeAlD
Loratadine—Desloratadine—CYP2C19—prostate cancer	0.00056	0.271	CrCbGaD
Loratadine—HRH1—prostate gland—prostate cancer	0.000549	0.04	CbGeAlD
Loratadine—KCNH2—renal system—prostate cancer	0.000467	0.034	CbGeAlD
Loratadine—KCNH2—urethra—prostate cancer	0.000459	0.0334	CbGeAlD
Loratadine—CYP2C8—renal system—prostate cancer	0.000427	0.0311	CbGeAlD
Loratadine—HRH1—epithelium—prostate cancer	0.000404	0.0294	CbGeAlD
Loratadine—HRH1—urethra—prostate cancer	0.000368	0.0268	CbGeAlD
Loratadine—KCNH2—bone marrow—prostate cancer	0.000353	0.0257	CbGeAlD
Loratadine—KCNH2—testis—prostate cancer	0.000302	0.022	CbGeAlD
Loratadine—ABCB1—prostate gland—prostate cancer	0.000301	0.0219	CbGeAlD
Loratadine—Azatadine—CYP3A4—prostate cancer	0.000298	0.145	CrCbGaD
Loratadine—CYP3A4—renal system—prostate cancer	0.000289	0.0211	CbGeAlD
Loratadine—CYP2D6—renal system—prostate cancer	0.000285	0.0207	CbGeAlD
Loratadine—CYP2C8—testis—prostate cancer	0.000276	0.0201	CbGeAlD
Loratadine—ABCB1—seminal vesicle—prostate cancer	0.000254	0.0185	CbGeAlD
Loratadine—HRH1—testis—prostate cancer	0.000242	0.0176	CbGeAlD
Loratadine—ABCB1—epithelium—prostate cancer	0.000221	0.0161	CbGeAlD
Loratadine—KCNH2—lymph node—prostate cancer	0.000219	0.0159	CbGeAlD
Loratadine—ABCB1—renal system—prostate cancer	0.000205	0.0149	CbGeAlD
Loratadine—ABCB1—urethra—prostate cancer	0.000201	0.0147	CbGeAlD
Loratadine—CYP2D6—testis—prostate cancer	0.000184	0.0134	CbGeAlD
Loratadine—HRH1—lymph node—prostate cancer	0.000175	0.0128	CbGeAlD
Loratadine—ABCB1—bone marrow—prostate cancer	0.000155	0.0113	CbGeAlD
Loratadine—ABCB1—testis—prostate cancer	0.000132	0.00964	CbGeAlD
Loratadine—ABCB1—lymph node—prostate cancer	9.6e-05	0.00699	CbGeAlD
Loratadine—Body temperature increased—Mitoxantrone—prostate cancer	8.79e-05	0.000644	CcSEcCtD
Loratadine—Abdominal pain—Mitoxantrone—prostate cancer	8.79e-05	0.000644	CcSEcCtD
Loratadine—Hypotension—Etoposide—prostate cancer	8.65e-05	0.000633	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—prostate cancer	8.64e-05	0.000633	CcSEcCtD
Loratadine—Asthenia—Estradiol—prostate cancer	8.57e-05	0.000628	CcSEcCtD
Loratadine—Ill-defined disorder—Capecitabine—prostate cancer	8.46e-05	0.00062	CcSEcCtD
Loratadine—Syncope—Docetaxel—prostate cancer	8.45e-05	0.000619	CcSEcCtD
Loratadine—Immune system disorder—Prednisone—prostate cancer	8.43e-05	0.000618	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—prostate cancer	8.43e-05	0.000617	CcSEcCtD
Loratadine—Arrhythmia—Prednisone—prostate cancer	8.34e-05	0.000611	CcSEcCtD
Loratadine—Palpitations—Docetaxel—prostate cancer	8.33e-05	0.00061	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—prostate cancer	8.31e-05	0.000609	CcSEcCtD
Loratadine—Loss of consciousness—Docetaxel—prostate cancer	8.28e-05	0.000607	CcSEcCtD
Loratadine—Alopecia—Prednisone—prostate cancer	8.25e-05	0.000604	CcSEcCtD
Loratadine—Malaise—Capecitabine—prostate cancer	8.23e-05	0.000603	CcSEcCtD
Loratadine—Somnolence—Etoposide—prostate cancer	8.23e-05	0.000603	CcSEcCtD
Loratadine—Cough—Docetaxel—prostate cancer	8.22e-05	0.000602	CcSEcCtD
Loratadine—Syncope—Capecitabine—prostate cancer	8.18e-05	0.000599	CcSEcCtD
Loratadine—Diarrhoea—Estradiol—prostate cancer	8.17e-05	0.000598	CcSEcCtD
Loratadine—Hypertension—Docetaxel—prostate cancer	8.13e-05	0.000596	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—prostate cancer	8.13e-05	0.000596	CcSEcCtD
Loratadine—Palpitations—Capecitabine—prostate cancer	8.06e-05	0.000591	CcSEcCtD
Loratadine—Myalgia—Docetaxel—prostate cancer	8.02e-05	0.000588	CcSEcCtD
Loratadine—Chest pain—Docetaxel—prostate cancer	8.02e-05	0.000588	CcSEcCtD
Loratadine—Loss of consciousness—Capecitabine—prostate cancer	8.02e-05	0.000587	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—prostate cancer	7.99e-05	0.000585	CcSEcCtD
Loratadine—Asthenia—Mitoxantrone—prostate cancer	7.98e-05	0.000585	CcSEcCtD
Loratadine—Fatigue—Etoposide—prostate cancer	7.98e-05	0.000584	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	7.97e-05	0.000584	CcSEcCtD
Loratadine—Cough—Capecitabine—prostate cancer	7.96e-05	0.000583	CcSEcCtD
Loratadine—Constipation—Etoposide—prostate cancer	7.91e-05	0.00058	CcSEcCtD
Loratadine—Pain—Etoposide—prostate cancer	7.91e-05	0.00058	CcSEcCtD
Loratadine—Dizziness—Estradiol—prostate cancer	7.9e-05	0.000578	CcSEcCtD
Loratadine—Hypertension—Capecitabine—prostate cancer	7.88e-05	0.000577	CcSEcCtD
Loratadine—Dry mouth—Docetaxel—prostate cancer	7.85e-05	0.000575	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—prostate cancer	7.8e-05	0.000571	CcSEcCtD
Loratadine—Chest pain—Capecitabine—prostate cancer	7.77e-05	0.000569	CcSEcCtD
Loratadine—Myalgia—Capecitabine—prostate cancer	7.77e-05	0.000569	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	7.71e-05	0.000565	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—prostate cancer	7.69e-05	0.000564	CcSEcCtD
Loratadine—Anaphylactic shock—Docetaxel—prostate cancer	7.69e-05	0.000563	CcSEcCtD
Loratadine—Discomfort—Capecitabine—prostate cancer	7.67e-05	0.000562	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—prostate cancer	7.67e-05	0.000562	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—prostate cancer	7.63e-05	0.000559	CcSEcCtD
Loratadine—Diarrhoea—Mitoxantrone—prostate cancer	7.61e-05	0.000558	CcSEcCtD
Loratadine—Dry mouth—Capecitabine—prostate cancer	7.6e-05	0.000557	CcSEcCtD
Loratadine—Vomiting—Estradiol—prostate cancer	7.59e-05	0.000556	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—prostate cancer	7.57e-05	0.000554	CcSEcCtD
Loratadine—Shock—Docetaxel—prostate cancer	7.57e-05	0.000554	CcSEcCtD
Loratadine—Nervous system disorder—Docetaxel—prostate cancer	7.54e-05	0.000553	CcSEcCtD
Loratadine—Ill-defined disorder—Prednisone—prostate cancer	7.54e-05	0.000552	CcSEcCtD
Loratadine—Rash—Estradiol—prostate cancer	7.53e-05	0.000552	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—prostate cancer	7.52e-05	0.000551	CcSEcCtD
Loratadine—Dermatitis—Estradiol—prostate cancer	7.52e-05	0.000551	CcSEcCtD
Loratadine—Tachycardia—Docetaxel—prostate cancer	7.51e-05	0.00055	CcSEcCtD
Loratadine—Headache—Estradiol—prostate cancer	7.48e-05	0.000548	CcSEcCtD
Loratadine—Skin disorder—Docetaxel—prostate cancer	7.47e-05	0.000547	CcSEcCtD
Loratadine—Agitation—Prednisone—prostate cancer	7.47e-05	0.000547	CcSEcCtD
Loratadine—Angioedema—Prednisone—prostate cancer	7.43e-05	0.000544	CcSEcCtD
Loratadine—Malaise—Prednisone—prostate cancer	7.33e-05	0.000537	CcSEcCtD
Loratadine—Shock—Capecitabine—prostate cancer	7.33e-05	0.000537	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—prostate cancer	7.31e-05	0.000536	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—prostate cancer	7.31e-05	0.000536	CcSEcCtD
Loratadine—Nervous system disorder—Capecitabine—prostate cancer	7.3e-05	0.000535	CcSEcCtD
Loratadine—Syncope—Prednisone—prostate cancer	7.29e-05	0.000534	CcSEcCtD
Loratadine—Tachycardia—Capecitabine—prostate cancer	7.27e-05	0.000532	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—prostate cancer	7.25e-05	0.000531	CcSEcCtD
Loratadine—Skin disorder—Capecitabine—prostate cancer	7.23e-05	0.00053	CcSEcCtD
Loratadine—Hypotension—Docetaxel—prostate cancer	7.19e-05	0.000526	CcSEcCtD
Loratadine—Loss of consciousness—Prednisone—prostate cancer	7.14e-05	0.000523	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—prostate cancer	7.12e-05	0.000521	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—prostate cancer	7.1e-05	0.00052	CcSEcCtD
Loratadine—Nausea—Estradiol—prostate cancer	7.09e-05	0.00052	CcSEcCtD
Loratadine—Vomiting—Mitoxantrone—prostate cancer	7.07e-05	0.000518	CcSEcCtD
Loratadine—Hypertension—Prednisone—prostate cancer	7.02e-05	0.000514	CcSEcCtD
Loratadine—Rash—Mitoxantrone—prostate cancer	7.01e-05	0.000514	CcSEcCtD
Loratadine—Dermatitis—Mitoxantrone—prostate cancer	7.01e-05	0.000513	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.01e-05	0.000513	CcSEcCtD
Loratadine—Headache—Mitoxantrone—prostate cancer	6.97e-05	0.000511	CcSEcCtD
Loratadine—Hypotension—Capecitabine—prostate cancer	6.96e-05	0.00051	CcSEcCtD
Loratadine—Insomnia—Docetaxel—prostate cancer	6.96e-05	0.00051	CcSEcCtD
Loratadine—Myalgia—Prednisone—prostate cancer	6.92e-05	0.000507	CcSEcCtD
Loratadine—Paraesthesia—Docetaxel—prostate cancer	6.91e-05	0.000506	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.87e-05	0.000503	CcSEcCtD
Loratadine—Somnolence—Docetaxel—prostate cancer	6.84e-05	0.000501	CcSEcCtD
Loratadine—Discomfort—Prednisone—prostate cancer	6.84e-05	0.000501	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—prostate cancer	6.81e-05	0.000499	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Capecitabine—prostate cancer	6.78e-05	0.000497	CcSEcCtD
Loratadine—Dyspepsia—Docetaxel—prostate cancer	6.77e-05	0.000496	CcSEcCtD
Loratadine—Insomnia—Capecitabine—prostate cancer	6.73e-05	0.000493	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—prostate cancer	6.7e-05	0.000491	CcSEcCtD
Loratadine—Paraesthesia—Capecitabine—prostate cancer	6.69e-05	0.00049	CcSEcCtD
Loratadine—Gastrointestinal disorder—Docetaxel—prostate cancer	6.64e-05	0.000486	CcSEcCtD
Loratadine—Asthenia—Etoposide—prostate cancer	6.64e-05	0.000486	CcSEcCtD
Loratadine—Anaphylactic shock—Prednisone—prostate cancer	6.63e-05	0.000486	CcSEcCtD
Loratadine—Fatigue—Docetaxel—prostate cancer	6.63e-05	0.000486	CcSEcCtD
Loratadine—Nausea—Mitoxantrone—prostate cancer	6.61e-05	0.000484	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—prostate cancer	6.59e-05	0.000483	CcSEcCtD
Loratadine—Pain—Docetaxel—prostate cancer	6.58e-05	0.000482	CcSEcCtD
Loratadine—Constipation—Docetaxel—prostate cancer	6.58e-05	0.000482	CcSEcCtD
Loratadine—Dyspepsia—Capecitabine—prostate cancer	6.55e-05	0.00048	CcSEcCtD
Loratadine—Shock—Prednisone—prostate cancer	6.52e-05	0.000478	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—prostate cancer	6.52e-05	0.000478	CcSEcCtD
Loratadine—Nervous system disorder—Prednisone—prostate cancer	6.5e-05	0.000477	CcSEcCtD
Loratadine—Tachycardia—Prednisone—prostate cancer	6.47e-05	0.000474	CcSEcCtD
Loratadine—Alopecia—Epirubicin—prostate cancer	6.45e-05	0.000473	CcSEcCtD
Loratadine—Skin disorder—Prednisone—prostate cancer	6.44e-05	0.000472	CcSEcCtD
Loratadine—Gastrointestinal disorder—Capecitabine—prostate cancer	6.43e-05	0.000471	CcSEcCtD
Loratadine—Fatigue—Capecitabine—prostate cancer	6.42e-05	0.00047	CcSEcCtD
Loratadine—Constipation—Capecitabine—prostate cancer	6.37e-05	0.000466	CcSEcCtD
Loratadine—Pain—Capecitabine—prostate cancer	6.37e-05	0.000466	CcSEcCtD
Loratadine—Feeling abnormal—Docetaxel—prostate cancer	6.34e-05	0.000464	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—prostate cancer	6.33e-05	0.000464	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—prostate cancer	6.3e-05	0.000461	CcSEcCtD
Loratadine—Gastrointestinal pain—Docetaxel—prostate cancer	6.29e-05	0.000461	CcSEcCtD
Loratadine—Tension—Epirubicin—prostate cancer	6.24e-05	0.000457	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—prostate cancer	6.22e-05	0.000456	CcSEcCtD
Loratadine—Nervousness—Epirubicin—prostate cancer	6.17e-05	0.000452	CcSEcCtD
Loratadine—Feeling abnormal—Capecitabine—prostate cancer	6.14e-05	0.00045	CcSEcCtD
Loratadine—Dizziness—Etoposide—prostate cancer	6.12e-05	0.000448	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—prostate cancer	6.1e-05	0.000447	CcSEcCtD
Loratadine—Gastrointestinal pain—Capecitabine—prostate cancer	6.09e-05	0.000446	CcSEcCtD
Loratadine—Body temperature increased—Docetaxel—prostate cancer	6.08e-05	0.000445	CcSEcCtD
Loratadine—Abdominal pain—Docetaxel—prostate cancer	6.08e-05	0.000445	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Prednisone—prostate cancer	6.04e-05	0.000443	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—prostate cancer	6.03e-05	0.000442	CcSEcCtD
Loratadine—Insomnia—Prednisone—prostate cancer	6e-05	0.000439	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—prostate cancer	5.97e-05	0.000437	CcSEcCtD
Loratadine—Paraesthesia—Prednisone—prostate cancer	5.96e-05	0.000436	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—prostate cancer	5.9e-05	0.000432	CcSEcCtD
Loratadine—Abdominal pain—Capecitabine—prostate cancer	5.89e-05	0.000431	CcSEcCtD
Loratadine—Body temperature increased—Capecitabine—prostate cancer	5.89e-05	0.000431	CcSEcCtD
Loratadine—Vomiting—Etoposide—prostate cancer	5.88e-05	0.000431	CcSEcCtD
Loratadine—Agitation—Epirubicin—prostate cancer	5.84e-05	0.000428	CcSEcCtD
Loratadine—Dyspepsia—Prednisone—prostate cancer	5.84e-05	0.000428	CcSEcCtD
Loratadine—Rash—Etoposide—prostate cancer	5.83e-05	0.000427	CcSEcCtD
Loratadine—Dermatitis—Etoposide—prostate cancer	5.83e-05	0.000427	CcSEcCtD
Loratadine—Headache—Etoposide—prostate cancer	5.8e-05	0.000425	CcSEcCtD
Loratadine—Tension—Doxorubicin—prostate cancer	5.77e-05	0.000423	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—prostate cancer	5.76e-05	0.000422	CcSEcCtD
Loratadine—Malaise—Epirubicin—prostate cancer	5.73e-05	0.00042	CcSEcCtD
Loratadine—Fatigue—Prednisone—prostate cancer	5.72e-05	0.000419	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—prostate cancer	5.71e-05	0.000418	CcSEcCtD
Loratadine—Syncope—Epirubicin—prostate cancer	5.7e-05	0.000418	CcSEcCtD
Loratadine—Constipation—Prednisone—prostate cancer	5.67e-05	0.000416	CcSEcCtD
Loratadine—Palpitations—Epirubicin—prostate cancer	5.62e-05	0.000411	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—prostate cancer	5.59e-05	0.000409	CcSEcCtD
Loratadine—Cough—Epirubicin—prostate cancer	5.55e-05	0.000406	CcSEcCtD
Loratadine—Asthenia—Docetaxel—prostate cancer	5.52e-05	0.000404	CcSEcCtD
Loratadine—Nausea—Etoposide—prostate cancer	5.5e-05	0.000403	CcSEcCtD
Loratadine—Hypertension—Epirubicin—prostate cancer	5.49e-05	0.000402	CcSEcCtD
Loratadine—Feeling abnormal—Prednisone—prostate cancer	5.47e-05	0.0004	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—prostate cancer	5.46e-05	0.0004	CcSEcCtD
Loratadine—Gastrointestinal pain—Prednisone—prostate cancer	5.42e-05	0.000397	CcSEcCtD
Loratadine—Myalgia—Epirubicin—prostate cancer	5.41e-05	0.000396	CcSEcCtD
Loratadine—Chest pain—Epirubicin—prostate cancer	5.41e-05	0.000396	CcSEcCtD
Loratadine—Agitation—Doxorubicin—prostate cancer	5.4e-05	0.000396	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.37e-05	0.000394	CcSEcCtD
Loratadine—Discomfort—Epirubicin—prostate cancer	5.35e-05	0.000392	CcSEcCtD
Loratadine—Asthenia—Capecitabine—prostate cancer	5.34e-05	0.000391	CcSEcCtD
Loratadine—Malaise—Doxorubicin—prostate cancer	5.3e-05	0.000389	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—prostate cancer	5.29e-05	0.000388	CcSEcCtD
Loratadine—Syncope—Doxorubicin—prostate cancer	5.27e-05	0.000386	CcSEcCtD
Loratadine—Diarrhoea—Docetaxel—prostate cancer	5.26e-05	0.000385	CcSEcCtD
Loratadine—Abdominal pain—Prednisone—prostate cancer	5.24e-05	0.000384	CcSEcCtD
Loratadine—Body temperature increased—Prednisone—prostate cancer	5.24e-05	0.000384	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—prostate cancer	5.2e-05	0.000381	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—prostate cancer	5.19e-05	0.00038	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—prostate cancer	5.17e-05	0.000379	CcSEcCtD
Loratadine—Cough—Doxorubicin—prostate cancer	5.13e-05	0.000376	CcSEcCtD
Loratadine—Shock—Epirubicin—prostate cancer	5.1e-05	0.000374	CcSEcCtD
Loratadine—Diarrhoea—Capecitabine—prostate cancer	5.09e-05	0.000373	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—prostate cancer	5.09e-05	0.000373	CcSEcCtD
Loratadine—Dizziness—Docetaxel—prostate cancer	5.09e-05	0.000373	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—prostate cancer	5.08e-05	0.000372	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—prostate cancer	5.06e-05	0.000371	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—prostate cancer	5.04e-05	0.000369	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—prostate cancer	5.01e-05	0.000367	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—prostate cancer	5.01e-05	0.000367	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.97e-05	0.000364	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—prostate cancer	4.95e-05	0.000362	CcSEcCtD
Loratadine—Dizziness—Capecitabine—prostate cancer	4.92e-05	0.000361	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—prostate cancer	4.9e-05	0.000359	CcSEcCtD
Loratadine—Vomiting—Docetaxel—prostate cancer	4.89e-05	0.000358	CcSEcCtD
Loratadine—Rash—Docetaxel—prostate cancer	4.85e-05	0.000355	CcSEcCtD
Loratadine—Hypotension—Epirubicin—prostate cancer	4.85e-05	0.000355	CcSEcCtD
Loratadine—Dermatitis—Docetaxel—prostate cancer	4.84e-05	0.000355	CcSEcCtD
Loratadine—Headache—Docetaxel—prostate cancer	4.82e-05	0.000353	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—prostate cancer	4.8e-05	0.000352	CcSEcCtD
Loratadine—Asthenia—Prednisone—prostate cancer	4.76e-05	0.000349	CcSEcCtD
Loratadine—Vomiting—Capecitabine—prostate cancer	4.73e-05	0.000347	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.73e-05	0.000346	CcSEcCtD
Loratadine—Shock—Doxorubicin—prostate cancer	4.72e-05	0.000346	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—prostate cancer	4.71e-05	0.000345	CcSEcCtD
Loratadine—Rash—Capecitabine—prostate cancer	4.69e-05	0.000344	CcSEcCtD
Loratadine—Insomnia—Epirubicin—prostate cancer	4.69e-05	0.000344	CcSEcCtD
Loratadine—Dermatitis—Capecitabine—prostate cancer	4.69e-05	0.000344	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—prostate cancer	4.68e-05	0.000343	CcSEcCtD
Loratadine—Headache—Capecitabine—prostate cancer	4.66e-05	0.000342	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—prostate cancer	4.66e-05	0.000342	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—prostate cancer	4.66e-05	0.000341	CcSEcCtD
Loratadine—Somnolence—Epirubicin—prostate cancer	4.61e-05	0.000338	CcSEcCtD
Loratadine—Nausea—Docetaxel—prostate cancer	4.57e-05	0.000335	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—prostate cancer	4.57e-05	0.000335	CcSEcCtD
Loratadine—Diarrhoea—Prednisone—prostate cancer	4.54e-05	0.000332	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—prostate cancer	4.48e-05	0.000329	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—prostate cancer	4.48e-05	0.000328	CcSEcCtD
Loratadine—Fatigue—Epirubicin—prostate cancer	4.47e-05	0.000328	CcSEcCtD
Loratadine—Pain—Epirubicin—prostate cancer	4.44e-05	0.000325	CcSEcCtD
Loratadine—Constipation—Epirubicin—prostate cancer	4.44e-05	0.000325	CcSEcCtD
Loratadine—Nausea—Capecitabine—prostate cancer	4.42e-05	0.000324	CcSEcCtD
Loratadine—Dizziness—Prednisone—prostate cancer	4.39e-05	0.000321	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.37e-05	0.00032	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—prostate cancer	4.34e-05	0.000318	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—prostate cancer	4.31e-05	0.000316	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—prostate cancer	4.27e-05	0.000313	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—prostate cancer	4.27e-05	0.000313	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—prostate cancer	4.24e-05	0.000311	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—prostate cancer	4.22e-05	0.00031	CcSEcCtD
Loratadine—Vomiting—Prednisone—prostate cancer	4.22e-05	0.000309	CcSEcCtD
Loratadine—Rash—Prednisone—prostate cancer	4.18e-05	0.000306	CcSEcCtD
Loratadine—Dermatitis—Prednisone—prostate cancer	4.18e-05	0.000306	CcSEcCtD
Loratadine—Headache—Prednisone—prostate cancer	4.15e-05	0.000304	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.14e-05	0.000304	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—prostate cancer	4.14e-05	0.000303	CcSEcCtD
Loratadine—Pain—Doxorubicin—prostate cancer	4.1e-05	0.000301	CcSEcCtD
Loratadine—Constipation—Doxorubicin—prostate cancer	4.1e-05	0.000301	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—prostate cancer	4.1e-05	0.0003	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—prostate cancer	4.1e-05	0.0003	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—prostate cancer	3.95e-05	0.00029	CcSEcCtD
Loratadine—Nausea—Prednisone—prostate cancer	3.94e-05	0.000289	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—prostate cancer	3.92e-05	0.000288	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—prostate cancer	3.79e-05	0.000278	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—prostate cancer	3.79e-05	0.000278	CcSEcCtD
Loratadine—Asthenia—Epirubicin—prostate cancer	3.72e-05	0.000273	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—prostate cancer	3.55e-05	0.00026	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—prostate cancer	3.44e-05	0.000252	CcSEcCtD
Loratadine—Dizziness—Epirubicin—prostate cancer	3.43e-05	0.000251	CcSEcCtD
Loratadine—Vomiting—Epirubicin—prostate cancer	3.3e-05	0.000242	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—prostate cancer	3.28e-05	0.000241	CcSEcCtD
Loratadine—Rash—Epirubicin—prostate cancer	3.27e-05	0.00024	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—prostate cancer	3.27e-05	0.000239	CcSEcCtD
Loratadine—Headache—Epirubicin—prostate cancer	3.25e-05	0.000238	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—prostate cancer	3.17e-05	0.000233	CcSEcCtD
Loratadine—Nausea—Epirubicin—prostate cancer	3.08e-05	0.000226	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—prostate cancer	3.05e-05	0.000224	CcSEcCtD
Loratadine—Rash—Doxorubicin—prostate cancer	3.03e-05	0.000222	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—prostate cancer	3.02e-05	0.000222	CcSEcCtD
Loratadine—Headache—Doxorubicin—prostate cancer	3.01e-05	0.00022	CcSEcCtD
Loratadine—Nausea—Doxorubicin—prostate cancer	2.85e-05	0.000209	CcSEcCtD
Loratadine—CYP3A4—Metabolism—NAT2—prostate cancer	3.74e-06	4.47e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.73e-06	4.46e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GGT1—prostate cancer	3.72e-06	4.45e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.7e-06	4.42e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NQO1—prostate cancer	3.69e-06	4.41e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ITPR1—prostate cancer	3.69e-06	4.41e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	3.68e-06	4.4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NCOA1—prostate cancer	3.67e-06	4.38e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB3—prostate cancer	3.66e-06	4.37e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NQO1—prostate cancer	3.66e-06	4.37e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGFR2—prostate cancer	3.65e-06	4.37e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TH—prostate cancer	3.64e-06	4.34e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GGT1—prostate cancer	3.64e-06	4.34e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.63e-06	4.33e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP19A1—prostate cancer	3.62e-06	4.32e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TH—prostate cancer	3.61e-06	4.31e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.6e-06	4.3e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LRP2—prostate cancer	3.59e-06	4.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.59e-06	4.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PLCB2—prostate cancer	3.59e-06	4.29e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.58e-06	4.28e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NCOA1—prostate cancer	3.58e-06	4.28e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP3A4—prostate cancer	3.57e-06	4.26e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.55e-06	4.24e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1B1—prostate cancer	3.54e-06	4.23e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP19A1—prostate cancer	3.53e-06	4.22e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—prostate cancer	3.52e-06	4.21e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—P4HB—prostate cancer	3.52e-06	4.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—prostate cancer	3.51e-06	4.19e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1B1—prostate cancer	3.51e-06	4.19e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—RXRA—prostate cancer	3.49e-06	4.17e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—TYMS—prostate cancer	3.48e-06	4.16e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—prostate cancer	3.44e-06	4.12e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GGT1—prostate cancer	3.43e-06	4.09e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.42e-06	4.09e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—RXRA—prostate cancer	3.41e-06	4.07e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GGT1—prostate cancer	3.4e-06	4.06e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.39e-06	4.06e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—LPL—prostate cancer	3.38e-06	4.04e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NCOA1—prostate cancer	3.37e-06	4.03e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—COMT—prostate cancer	3.36e-06	4.02e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HIF1A—prostate cancer	3.35e-06	4.01e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—prostate cancer	3.35e-06	4e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NCOA1—prostate cancer	3.35e-06	4e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.34e-06	3.99e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.33e-06	3.97e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.3e-06	3.94e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ITPR1—prostate cancer	3.29e-06	3.93e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MED12—prostate cancer	3.28e-06	3.92e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—COMT—prostate cancer	3.28e-06	3.92e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—LEP—prostate cancer	3.27e-06	3.91e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—prostate cancer	3.27e-06	3.9e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1A1—prostate cancer	3.27e-06	3.9e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GNG5—prostate cancer	3.26e-06	3.89e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CAV1—prostate cancer	3.24e-06	3.88e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ERCC2—prostate cancer	3.24e-06	3.87e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.24e-06	3.87e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ITPR1—prostate cancer	3.21e-06	3.84e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—RXRA—prostate cancer	3.21e-06	3.83e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—prostate cancer	3.21e-06	3.83e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—RXRA—prostate cancer	3.18e-06	3.8e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.14e-06	3.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ESR1—prostate cancer	3.13e-06	3.74e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—TYMS—prostate cancer	3.11e-06	3.72e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.1e-06	3.7e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—COMT—prostate cancer	3.09e-06	3.69e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—prostate cancer	3.08e-06	3.68e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—prostate cancer	3.07e-06	3.67e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—COMT—prostate cancer	3.07e-06	3.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BAD—prostate cancer	3.05e-06	3.65e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—prostate cancer	3.05e-06	3.64e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—prostate cancer	3.04e-06	3.64e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—TYMS—prostate cancer	3.04e-06	3.63e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ITPR1—prostate cancer	3.03e-06	3.62e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—LPL—prostate cancer	3.02e-06	3.61e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ITPR1—prostate cancer	3e-06	3.59e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—prostate cancer	3e-06	3.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.99e-06	3.58e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARA—prostate cancer	2.99e-06	3.57e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.97e-06	3.55e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—prostate cancer	2.96e-06	3.53e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	2.96e-06	3.53e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.95e-06	3.53e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—LPL—prostate cancer	2.95e-06	3.52e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGF—prostate cancer	2.92e-06	3.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IRS1—prostate cancer	2.92e-06	3.49e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.91e-06	3.48e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.9e-06	3.47e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ACHE—prostate cancer	2.9e-06	3.47e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.89e-06	3.45e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.87e-06	3.43e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—TYMS—prostate cancer	2.86e-06	3.42e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A1—prostate cancer	2.85e-06	3.4e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—TYMS—prostate cancer	2.84e-06	3.39e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GSK3B—prostate cancer	2.84e-06	3.39e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.83e-06	3.38e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ERCC2—prostate cancer	2.82e-06	3.37e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CAV1—prostate cancer	2.81e-06	3.35e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—prostate cancer	2.8e-06	3.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—INS—prostate cancer	2.8e-06	3.34e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.79e-06	3.33e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.78e-06	3.32e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—LPL—prostate cancer	2.78e-06	3.32e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—LPL—prostate cancer	2.75e-06	3.29e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.75e-06	3.28e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CREBBP—prostate cancer	2.74e-06	3.27e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—prostate cancer	2.72e-06	3.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF1—prostate cancer	2.71e-06	3.23e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—EGFR—prostate cancer	2.69e-06	3.22e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.68e-06	3.21e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.68e-06	3.2e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARA—prostate cancer	2.67e-06	3.19e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.66e-06	3.18e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.66e-06	3.18e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—prostate cancer	2.65e-06	3.17e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ERCC2—prostate cancer	2.64e-06	3.15e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.62e-06	3.13e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	2.62e-06	3.12e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARA—prostate cancer	2.6e-06	3.11e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	2.6e-06	3.1e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	2.57e-06	3.07e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	2.57e-06	3.07e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.56e-06	3.06e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—prostate cancer	2.54e-06	3.04e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CAV1—prostate cancer	2.51e-06	2.99e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.5e-06	2.99e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.5e-06	2.98e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF2—prostate cancer	2.49e-06	2.97e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—prostate cancer	2.48e-06	2.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOS3—prostate cancer	2.45e-06	2.93e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARA—prostate cancer	2.45e-06	2.93e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CAV1—prostate cancer	2.45e-06	2.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.44e-06	2.91e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARA—prostate cancer	2.43e-06	2.9e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—INS—prostate cancer	2.42e-06	2.89e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NQO1—prostate cancer	2.41e-06	2.88e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.39e-06	2.86e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JAK2—prostate cancer	2.38e-06	2.85e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TH—prostate cancer	2.38e-06	2.84e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CREBBP—prostate cancer	2.37e-06	2.83e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	2.34e-06	2.79e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MDM2—prostate cancer	2.33e-06	2.78e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.31e-06	2.76e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CAV1—prostate cancer	2.31e-06	2.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ERBB2—prostate cancer	2.29e-06	2.74e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CAV1—prostate cancer	2.29e-06	2.73e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.28e-06	2.73e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	2.26e-06	2.71e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.25e-06	2.69e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GGT1—prostate cancer	2.24e-06	2.68e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—prostate cancer	2.23e-06	2.66e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.21e-06	2.64e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.18e-06	2.61e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CXCL8—prostate cancer	2.18e-06	2.6e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.17e-06	2.6e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—INS—prostate cancer	2.16e-06	2.58e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	2.13e-06	2.54e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NOS3—prostate cancer	2.12e-06	2.54e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.12e-06	2.53e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—INS—prostate cancer	2.11e-06	2.52e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	2.1e-06	2.51e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.1e-06	2.51e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—RXRA—prostate cancer	2.1e-06	2.51e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—prostate cancer	2.08e-06	2.49e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.08e-06	2.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—prostate cancer	2.08e-06	2.48e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—prostate cancer	2.07e-06	2.47e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CREBBP—prostate cancer	2.07e-06	2.47e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—prostate cancer	2.03e-06	2.42e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—COMT—prostate cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.01e-06	2.4e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.01e-06	2.4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.01e-06	2.4e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—INS—prostate cancer	1.99e-06	2.37e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.98e-06	2.37e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—INS—prostate cancer	1.97e-06	2.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—prostate cancer	1.97e-06	2.35e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.96e-06	2.34e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.96e-06	2.34e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.96e-06	2.34e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—prostate cancer	1.96e-06	2.34e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.95e-06	2.33e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.94e-06	2.32e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.93e-06	2.31e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.91e-06	2.28e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NOS3—prostate cancer	1.9e-06	2.26e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TYMS—prostate cancer	1.87e-06	2.23e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EP300—prostate cancer	1.87e-06	2.23e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NOS3—prostate cancer	1.85e-06	2.21e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.85e-06	2.21e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.85e-06	2.21e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.83e-06	2.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—LPL—prostate cancer	1.81e-06	2.17e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SRC—prostate cancer	1.81e-06	2.17e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.77e-06	2.11e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.75e-06	2.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—prostate cancer	1.75e-06	2.09e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.75e-06	2.09e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NOS3—prostate cancer	1.74e-06	2.08e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.74e-06	2.08e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.73e-06	2.07e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NOS3—prostate cancer	1.73e-06	2.06e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.71e-06	2.04e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—prostate cancer	1.69e-06	2.02e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTGS2—prostate cancer	1.69e-06	2.02e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.63e-06	1.95e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—prostate cancer	1.63e-06	1.94e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.62e-06	1.94e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—EP300—prostate cancer	1.62e-06	1.93e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.61e-06	1.92e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARA—prostate cancer	1.6e-06	1.92e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.6e-06	1.91e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.59e-06	1.9e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EGFR—prostate cancer	1.59e-06	1.9e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.58e-06	1.89e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—prostate cancer	1.51e-06	1.81e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CAV1—prostate cancer	1.51e-06	1.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—prostate cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—prostate cancer	1.48e-06	1.76e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—EP300—prostate cancer	1.44e-06	1.72e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—EP300—prostate cancer	1.41e-06	1.68e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—prostate cancer	1.39e-06	1.66e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.38e-06	1.65e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—prostate cancer	1.38e-06	1.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.37e-06	1.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—prostate cancer	1.34e-06	1.6e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—EP300—prostate cancer	1.33e-06	1.58e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—EP300—prostate cancer	1.31e-06	1.57e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—INS—prostate cancer	1.3e-06	1.55e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.27e-06	1.52e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—prostate cancer	1.22e-06	1.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.21e-06	1.44e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.43e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NOS3—prostate cancer	1.14e-06	1.36e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.13e-06	1.35e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.07e-06	1.27e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.05e-06	1.26e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.04e-06	1.25e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.04e-06	1.24e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.81e-07	1.17e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—prostate cancer	9.76e-07	1.17e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—prostate cancer	9.72e-07	1.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—prostate cancer	9.09e-07	1.09e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—prostate cancer	8.71e-07	1.04e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—EP300—prostate cancer	8.67e-07	1.04e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—prostate cancer	8.5e-07	1.02e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—prostate cancer	8.01e-07	9.57e-06	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—prostate cancer	7.94e-07	9.49e-06	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.41e-07	7.66e-06	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—prostate cancer	5.24e-07	6.26e-06	CbGpPWpGaD
